Table 2.
Study Groups | ABC Compliant | Non-compliant |
---|---|---|
[N (%)] | [N (%)] | |
A | 12,499 (65.1) | 6,688 (34.9) |
B | 14,021 (73.1) | 5,166 (26.9) |
C | 9,347 (48.7) | 9,840 (51.3) |
Hypertension | 6,034 (49.4) | 6,189 (50.6) |
Heart failure | 562 (33.8) | 1,101 (66.2) |
Ischemic stroke or TIA | 1,538 (55.4) | 1,236 (44.6) |
Diabetes mellitus | 1,741 (43.5) | 2,259 (56.5) |
Coronary artery disease | 740 (25.0) | 2,219 (75.0) |
Peripheral arterial disease | 94 (61.4) | 59 (38.6) |
All ABC | 4,365 (22.8) | 14,822 (77.2) |
A, avoid stroke; B, better symptoms management; C, cardiovascular and other comorbidities; ABC, the full ABC pathway compliance; TIA, transient ischaemic attack.